Provider
P51-22 Medicare Requirements for Reporting Provider Demographic Changes
Program effective Date: Sep 01, 2022
Search Results
Displaying 1781 - 1790 of 3661 results
Provider
Ryplazim® (plasminogen,human-tvmh) - Medicaid
Prior Authorization, Quantity Limit
Program effective Date: Dec 01, 2024
Provider
Tarpeyo™ (budesonide) - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Nov 01, 2024
Provider
Recorlev® (levoketoconazole) - Commercial - Effective Date 02/01/2025
Prior Authorization, Quantity Limit
Program effective Date: Feb 01, 2025
Benefits & Coverage
SecureBlue 2023 Summary of Benefits
Provider
QP77-22 Reminder: Submit Finger and Toe Anatomical Modifiers
Program effective Date: Sep 28, 2022
Provider
QP78-22 Laboratory Reimbursement Policy Change will not be Implemented
Program effective Date: Sep 28, 2022
Provider
QP73-22 Commercial Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective November 1, 2022
Program effective Date: Sep 14, 2022
Provider
2022 September Bulletins
Program effective Date: Sep 01, 2022
Provider
Ryplazim® (plasminogen,human-tvmh) - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Dec 01, 2024